Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group.

Authors :: Hoechstetter MA
Busch R
Eichhorst B
Bühler A
Winkler D
Eckart MJ
Vehling-Kaiser U
Schimke H
Jäger U
Hurtz HJ
Hopfinger G
Hartmann F
Fuss H
Abenhardt W
Blau I
Freier W
Müller L
Goebeler M
Wendtner CM
Bahlo J
Fischer K
Bentz M
Emmerich B
Döhner H
Hallek M
Stilgenbauer S
Source :: Leukemia [Leukemia] 2017 Dec; Vol. 31 (12), pp. 2833-2837. Date of Electronic Publication: 2017 Aug 14.
Publication Year :: 2017

Subjects :: Disease-Free Survival
Female
Humans
Lymphocytes drug effects
Male
Middle Aged
Risk
Vidarabine therapeutic use
Antineoplastic Agents therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Vidarabine analogs & derivatives

Full Text Access

Tools